CATALAYER NEWS
What would 200% US tariffs on generic drugs mean for China’s pharmaceutical industry?
Source: SCMP Business · 2026-07-22
Despite Washington’s move to tighten policy on pharmaceutical trade with a fresh threat of 100 per cent tariffs on generic drug imports, analysts say China’s pharmaceutical rise is now tariff-proof, making its ascent in the global supply chain look irreversible. US President Donald Trump announced plans on Tuesday to impose escalating tariffs on all generic drugs shipped to the country beginning in August 2028. Under the proposed schedule, tariffs would rise to 100 per cent within the first year
MORE FROM SCMP BUSINESS
From CXMT to Zhipu: How Alibaba’s investment pays off with a growing AI and chip portfolio
2026-07-28
Sun Life targets Asia’s booming wealth transfer market with new platform
2026-07-28
China’s home-grown DUV progress not the biggest threat to ASML, analysts say
2026-07-28
Hong Kong’s Exchange Fund first-half earnings fall 37% on equity slump, softer bond income
2026-07-28
RELATED ON CATALAYER
RELATED MARKETS
Prediction Markets